top of page

Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies

Dilcher R, Wall S, Gros M, Katzdobler S, Wagemann O, Palleis C, Weidinger E, Fietzek U, Bernhardt A, Kurz C, Ferschmann C, Scheifele M, Zaganjori M, Gnorich J, Burger K, Janowitz D, Rauchmann BS, Stocklein S, Bartenstein P, Villemagne V, Seibyl J, Sabri O, Barthel H, Perneczky R, Schoberl F, Zwergal A, Hoglinger GU, Levin J, Franzmeier N, Brendel M.

Alzheimers Dement. 2024 Sep 12. doi: 10.1002/alz.14185. Online ahead of print.

2024

PMID

39263969

PSP/CBD

Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies
bottom of page